Abstract
This study aimed to evaluate prevalence and risk factors of metabolic syndrome in human immunodeficiency virus–infected patients on highly active antiretroviral therapy. The prevalence of metabolic syndrome was 18.5%. The patients with metabolic syndrome had significantly higher fasting blood sugar level, triglyceride level, systolic blood pressure, waist circumference, and body mass index but lower high-density lipoprotein cholesterol than those without metabolic syndrome. A significant difference of carbohydrate intake between groups was observed. These findings indicated that metabolic syndrome could be found in human immunodeficiency virus–infected patients on highly active antiretroviral therapy, and the management of this problem should be taken into consideration.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
